ANDA 90974, held by Padagis Israel. Clobetasol Propionate.
As of Nov 16, 2026, ANDA 90974 (Clobetasol Propionate), held by Padagis Israel, was first approved by FDA on Aug 9, 2012, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 9, 2012 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Clobetasol Propionate0.05% · shampoo;topical | Clobetasol Propionate | Rx |
| Sep 6, 2019 | Supplement 5Labeling · Standard review | Approved | None posted |
| Aug 9, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters